{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":246905,"items":[{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T19:58:41Z","timestamp":1720382321448},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1016\/s0145-2126(99)90012-7","type":"journal-article","created":{"date-parts":[[2004,5,24]],"date-time":"2004-05-24T06:50:20Z","timestamp":1085381420000},"page":"IN25-S57","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Chronic myelomonocytic leukemia, juvenile myelomonocytic leukemia"],"prefix":"10.1016","volume":"23","member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212699900127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212699900127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T01:51:37Z","timestamp":1549590697000},"score":12.13682,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212699900127"}},"issued":{"date-parts":[[1999,4]]},"references-count":0,"alternative-id":["S0145212699900127"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(99)90012-7","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[1999,4]]}},{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:57:02Z","timestamp":1770775022770,"version":"3.50.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T00:00:00Z","timestamp":1213228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T00:00:00Z","timestamp":1213228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1038\/leu.2008.162","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T10:11:14Z","timestamp":1213265474000},"page":"1335-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia"],"prefix":"10.1038","volume":"22","author":[{"given":"P D","family":"Emanuel","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,6,12]]},"reference":[{"key":"BFleu2008162_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189\u2013199.","journal-title":"Br J Haematol"},{"key":"BFleu2008162_CR2","first-page":"183","volume":"23","author":"LR Wasserman","year":"1986","unstructured":"Wasserman LR . Polycythemia Vera Study Group: a historical perspective. Semin Hematol 1986; 23: 183\u2013187.","journal-title":"Semin Hematol"},{"key":"BFleu2008162_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.leu.2404946","volume":"22","author":"A Tefferi","year":"2008","unstructured":"Tefferi A . The history of myeloproliferative disorders: before and after Dameshek. Leukemia 2008; 22: 3\u201313.","journal-title":"Leukemia"},{"key":"BFleu2008162_CR4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","volume":"87","author":"JM Bennett","year":"1994","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Proposals by the French\u2013American\u2013British Cooperative Leukaemia Group. Br J Haematol 1994; 87: 746\u2013754.","journal-title":"Br J Haematol"},{"key":"BFleu2008162_CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0145-2126(97)00192-6","volume":"22","author":"U Germing","year":"1998","unstructured":"Germing U, Gattermann N, Minning H, Heyll A, Aul C . Problems in the classification of CMML\u2014dysplastic versus proliferative type. Leuk Res 1998; 22: 871\u2013878.","journal-title":"Leuk Res"},{"key":"BFleu2008162_CR6","first-page":"47","volume-title":"World Health Organization Classification of Tumours: Tumours of the Haematopoietic and Lymphoid Tissues","author":"JW Vardiman","year":"2001","unstructured":"Vardiman JW, Pierre R, Bain B, Bennett JM, Imbert M, Brunning RD et al. WHO histological classification of myelodysplastic\/myeloproliferative diseases. In Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumours: Tumours of the Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC) Press: Lyon, France, 2001, pp 47\u201359."},{"key":"BFleu2008162_CR7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3324\/haematol.11051","volume":"92","author":"U Germing","year":"2007","unstructured":"Germing U, Strupp C, Knipp S, Kuendgen A, Giagounidis A, Hildebrandt B et al. Chronic myelomonocytic leukemia in the light of the WHO proposals. Haematologica 2007; 92: 974\u2013977.","journal-title":"Haematologica"},{"key":"BFleu2008162_CR8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","volume":"110","author":"A Tefferi","year":"2007","unstructured":"Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092\u20131097.","journal-title":"Blood"},{"key":"BFleu2008162_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","volume":"22","author":"A Tefferi","year":"2008","unstructured":"Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14\u201322.","journal-title":"Leukemia"},{"key":"BFleu2008162_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/blood.V43.3.341.341","volume":"43","author":"AJ Altman","year":"1974","unstructured":"Altman AJ, Palmer CG, Baehner RL . Juvenile \u2018chronic granulocytic\u2019 leukemia; a panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells. Blood 1974; 43: 341\u2013350.","journal-title":"Blood"},{"key":"BFleu2008162_CR11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/1097-0142(1984)54:4<675::AID-CNCR2820540415>3.0.CO;2-Q","volume":"54","author":"H Castro-Malaspina","year":"1984","unstructured":"Castro-Malaspina H, Schaison G, Passe S, Pasquier A, Berger R, Bayle-Weisgerber C et al. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors. Cancer 1984; 54: 675\u2013686.","journal-title":"Cancer"},{"key":"BFleu2008162_CR12","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V67.5.1382.1382","volume":"67","author":"Z Estrov","year":"1986","unstructured":"Estrov Z, Grunberger T, Chan HSL, Freedman MH . Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures. Blood 1986; 67: 1382\u20131387.","journal-title":"Blood"},{"key":"BFleu2008162_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0145-2126(87)90006-3","volume":"11","author":"DE Hogge","year":"1987","unstructured":"Hogge DE, Shannon KM, Kalousek DK, Schonberg S, Schaffner V, Zoger S et al. Juvenile monosomy 7 syndrome: evidence that the disease originates in a pluripotent hemopoietic stem cell. Leuk Res 1987; 11: 705\u2013709.","journal-title":"Leuk Res"},{"key":"BFleu2008162_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI113748","volume":"82","author":"GC Bagby","year":"1988","unstructured":"Bagby GC, Dinarello CA, Neerhout RC, Ridgway D, McCall E . Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type. J Clin Invest 1988; 82: 143\u2013146.","journal-title":"J Clin Invest"},{"key":"BFleu2008162_CR15","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood.V85.8.1985.bloodjournal8581985","volume":"85","author":"S Luna-Fineman","year":"1995","unstructured":"Luna-Fineman S, Shannon KM, Lange BJ . Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood 1995; 85: 1985\u20131999.","journal-title":"Blood"},{"key":"BFleu2008162_CR16","first-page":"3534","volume":"89","author":"CM Niemeyer","year":"1997","unstructured":"Niemeyer CM, Arico M, Basso G, Biondi A, Cantu-Rajnoldi A, Creutzig U et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood 1997; 89: 3534\u20133543.","journal-title":"Blood"},{"key":"BFleu2008162_CR17","first-page":"365","volume":"91","author":"CM Niemeyer","year":"1989","unstructured":"Niemeyer CM, Fenu S, Hasle H, Mann G, Stary J, van Wering E . Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1989; 91: 365\u2013367.","journal-title":"Blood"},{"key":"BFleu2008162_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"TR Golub","year":"1994","unstructured":"Golub TR, Barker GF, Lovett M, Gilliland DG . Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77: 307\u2013316.","journal-title":"Cell"},{"key":"BFleu2008162_CR19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","volume":"106","author":"DP Steensma","year":"2005","unstructured":"Steensma DP, Dewald GW, Lasho TL, Powell HL, McClure RF, Levine RL et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u2018atypical\u2019 myeloproliferative disorders and myelodysplastic syndromes. Blood 2005; 106: 1207\u20131209.","journal-title":"Blood"},{"key":"BFleu2008162_CR20","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","volume":"106","author":"J Jelinek","year":"2005","unstructured":"Jelinek J, Oki Y, Gharibyan V, Bueso-Ramos C, Prchal JT, Verstovsek S et al. JAK2 mutation 1849G&gt;T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood 2005; 106: 3370\u20133373.","journal-title":"Blood"},{"key":"BFleu2008162_CR21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ccr.2007.08.031","volume":"12","author":"BH Lee","year":"2007","unstructured":"Lee BH, Tothova Z, Levine RL, Anderson K, Buza-Vidas N, Cullen DE et al. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 2007; 12: 367\u2013380.","journal-title":"Cancer Cell"},{"key":"BFleu2008162_CR22","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/1042819042000207271","volume":"45","author":"U Germing","year":"2004","unstructured":"Germing U, Kundgen A, Gattermann N . Risk assessment in chronic myelomonocytic leukemia (CMML). Leuk Lymphoma 2004; 45: 1311\u20131318.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2008162_CR23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","volume":"99","author":"F Onida","year":"2002","unstructured":"Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002; 99: 840\u2013849.","journal-title":"Blood"},{"key":"BFleu2008162_CR24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10428190701216386","volume":"48","author":"M Beran","year":"2007","unstructured":"Beran M, Wen S, Shen Y, Onida F, Jelinek J, Cortes J et al. Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation of the M.D. anderson prognostic scoring system. Leuk Lymphoma 2007; 48: 1150\u20131160.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2008162_CR25","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1182\/blood-2007-07-103960","volume":"111","author":"Y Oki","year":"2008","unstructured":"Oki Y, Jelinek J, Shen L, Kantarjian HM, Issa JP . Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia. Blood 2008; 111: 2382\u20132384.","journal-title":"Blood"},{"key":"BFleu2008162_CR26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.leu.2400565","volume":"11","author":"V Najfeld","year":"1997","unstructured":"Najfeld V, Vlachos A, Parker R, Burnett W, Scalise A, Fruchtman S . Evidence for the embryonic origin of partial chromosome 7 deletion in monozygotic twins with juvenile chronic myelogenous leukemia. Leukemia 1997; 11: 306\u2013312.","journal-title":"Leukemia"},{"key":"BFleu2008162_CR27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1017\/CBO9780511471001.023","volume-title":"Childhood Leukemias","author":"CM Niemeyer","year":"2006","unstructured":"Niemeyer CM, Locatelli F . Chronic myeloproliferative disorders. In: C-H Pui (ed). Childhood Leukemias. Cambridge University Press: New York, 2006, pp 571\u2013598."},{"key":"BFleu2008162_CR28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2141.1999.01435.x","volume":"105","author":"PD Emanuel","year":"1999","unstructured":"Emanuel PD . Myelodysplasia and myeloproliferative disorders in childhood\u2014an update. Br J Haematol 1999; 105: 852\u2013863.","journal-title":"Br J Haematol"},{"key":"BFleu2008162_CR29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2141.1992.tb06398.x","volume":"80","author":"MH Freedman","year":"1992","unstructured":"Freedman MH, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF et al. Central role of tumor necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukemia. Br J Haematol 1992; 80: 40\u201348.","journal-title":"Br J Haematol"},{"key":"BFleu2008162_CR30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.1.5593.679","volume":"1","author":"DJ Weatherall","year":"1968","unstructured":"Weatherall DJ, Edwards JA, Donohoe WT . Haemoglobin and red cell enzyme changes in juvenile myeloid leukaemia. Br Med J 1968; 1: 679\u2013681.","journal-title":"Br Med J"},{"key":"BFleu2008162_CR31","first-page":"1017","volume":"19","author":"PD Emanuel","year":"1991","unstructured":"Emanuel PD, Bates LJ, Zhu SW, Castleberry RP, Gualtieri RJ, Zuckerman KS . The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Exp Hematol 1991; 19: 1017\u20131024.","journal-title":"Exp Hematol"},{"key":"BFleu2008162_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0145-2126(95)00129-8","volume":"20","author":"T Siitonen","year":"1996","unstructured":"Siitonen T, Zheng A, Savolainen E-R, Koistinen P . Spontaneous granulocyte-macrophage colony growth by peripheral blood mononuclear cells in myeloproliferative disorders. Leuk Res 1996; 20: 187\u2013195.","journal-title":"Leuk Res"},{"key":"BFleu2008162_CR33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","volume":"77","author":"PD Emanuel","year":"1991","unstructured":"Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS . Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991; 77: 925\u2013929.","journal-title":"Blood"},{"key":"BFleu2008162_CR34","first-page":"1382","volume":"290","author":"JF Prchal","year":"1974","unstructured":"Prchal JF, Axelrad AA . Bone marrow responses in polycythemia vera. N Engl J Med 1974; 290: 1382.","journal-title":"N Engl J Med"},{"key":"BFleu2008162_CR35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI115009","volume":"87","author":"CH Dai","year":"1991","unstructured":"Dai CH, Kranyz SB, Means RT, Horn ST, Gilbert HS . Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. J Clin Invest 1991; 87: 391\u2013396.","journal-title":"J Clin Invest"},{"key":"BFleu2008162_CR36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","volume":"83","author":"PN Correa","year":"1994","unstructured":"Correa PN, Eskinazi D, Axelrad AA . Circulating erythroid progenitors in polycythemai vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. Blood 1994; 83: 99\u2013112.","journal-title":"Blood"},{"key":"BFleu2008162_CR37","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood.V96.10.3310","volume":"96","author":"AA Axelrad","year":"2000","unstructured":"Axelrad AA, Eskinazi D, Correa PN, Amato D . Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHuMGDF) in essential thrombocythemia. Blood 2000; 96: 3310\u20133321.","journal-title":"Blood"},{"key":"BFleu2008162_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V85.1.21.bloodjournal85121","volume":"85","author":"L Busque","year":"1995","unstructured":"Busque L, Gilliland G, Prchal JT, Sieff CA, Weinstein HJ, Sokol JM et al. Clonality in juvenile chronic myelogenous leukemia. Blood 1995; 85: 21\u201330.","journal-title":"Blood"},{"key":"BFleu2008162_CR39","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V96.6.2310","volume":"96","author":"LJN Cooper","year":"2000","unstructured":"Cooper LJN, Shannon KM, Loken MR, Weaver M, Stephens K, Sievers EL . Evidence that juvenile myelomonocytic leukemia can arise from a pluripotent stem cell. Blood 2000; 96: 2310\u20132313.","journal-title":"Blood"},{"key":"BFleu2008162_CR40","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V84.10.3435.3435","volume":"84","author":"R Kalra","year":"1994","unstructured":"Kalra R, Paderanga D, Olson K, Shannon KM . Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood 1994; 84: 3435\u20133439.","journal-title":"Blood"},{"key":"BFleu2008162_CR41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199403033300903","volume":"330","author":"KM Shannon","year":"1994","unstructured":"Shannon KM, O\u2019Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1994; 330: 597\u2013601.","journal-title":"N Engl J Med"},{"key":"BFleu2008162_CR42","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1182\/blood.V88.11.4314.bloodjournal88114314","volume":"88","author":"DK Miles","year":"1996","unstructured":"Miles DK, Freedman MH, Stephens K, Pallavicini M, Sievers EL, Weaver M et al. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Blood 1996; 88: 4314\u20134320.","journal-title":"Blood"},{"key":"BFleu2008162_CR43","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJM199706123362404","volume":"336","author":"L Side","year":"1997","unstructured":"Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 1997; 336: 1713\u20131720.","journal-title":"N Engl J Med"},{"key":"BFleu2008162_CR44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","volume":"92","author":"LE Side","year":"1998","unstructured":"Side LE, Emanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 1998; 92: 267\u2013272.","journal-title":"Blood"},{"key":"BFleu2008162_CR45","first-page":"4682","volume":"49","author":"JL Bos","year":"1989","unstructured":"Bos JL . ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682\u20134689.","journal-title":"Cancer Res"},{"key":"BFleu2008162_CR46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","volume":"7","author":"S Schubbert","year":"2007","unstructured":"Schubbert S, Shannon K, Bollag G . Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007; 7: 295\u2013308.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2008162_CR47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood.V77.3.594.594","volume":"77","author":"A Neubauer","year":"1991","unstructured":"Neubauer A, Shannon KM, Liu E . Mutations of the ras proto-oncogenes in childhood monosomy 7. Blood 1991; 77: 594\u2013598.","journal-title":"Blood"},{"key":"BFleu2008162_CR48","first-page":"263","volume":"7","author":"M Lubbert","year":"1992","unstructured":"Lubbert M, Mirro J, Kitchingman G, McCormick F, Mertelesmann R, Herrmann F et al. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Oncogene 1992; 7: 263\u2013268.","journal-title":"Oncogene"},{"key":"BFleu2008162_CR49","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.V83.8.2248.2248","volume":"83","author":"J Miyauchi","year":"1994","unstructured":"Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S . Mutations of the N-ras gene in juvenile chronic myelogenous leucemia. Blood 1994; 83: 2248\u20132254.","journal-title":"Blood"},{"key":"BFleu2008162_CR50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.leu.2401240","volume":"13","author":"C Flotho","year":"1999","unstructured":"Flotho C, Valcamonica S, Mach-Pascual S, Schmahl G, Corral L, Ritterbach J et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999; 13: 32\u201337.","journal-title":"Leukemia"},{"key":"BFleu2008162_CR51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pbc.20644","volume":"46","author":"JO Lauchle","year":"2006","unstructured":"Lauchle JO, Braun BS, Loh ML, Shannon K . Inherited predispositions and hyperactive Ras in myeloid leukemogenesis. Pediatr Blood Cancer 2006; 46: 579\u2013585.","journal-title":"Pediatr Blood Cancer"},{"key":"BFleu2008162_CR52","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3476(97)70273-7","volume":"130","author":"B Bader-Meunier","year":"1997","unstructured":"Bader-Meunier B, Tchernia G, Mielot F, Fontaine JL, Thomas C, Lyonnet S et al. Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1997; 130: 885\u2013889.","journal-title":"J Pediatr"},{"key":"BFleu2008162_CR53","first-page":"857","volume":"130","author":"LE Side","year":"1997","unstructured":"Side LE, Shannon KM . Myeloid disorders in infants with Noonan syndrome and a resident's \u2018rule\u2019 recalled. J Pediatr 1997; 130: 857\u2013859.","journal-title":"J Pediatr"},{"key":"BFleu2008162_CR54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00043426-199911000-00014","volume":"21","author":"K Choong","year":"1999","unstructured":"Choong K, Freedman MH, Chitayat D . Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol 1999; 21: 523\u2013527.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2008162_CR55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001; 29: 465\u2013468.","journal-title":"Nat Genet"},{"key":"BFleu2008162_CR56","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","volume":"70","author":"M Tartaglia","year":"2002","unstructured":"Tartaglia M, Kalidas K, Shaw A . PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002; 70: 1555\u20131563.","journal-title":"Am J Hum Genet"},{"key":"BFleu2008162_CR57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","volume":"34","author":"M Tartaglia","year":"2003","unstructured":"Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leucemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34: 148\u2013150.","journal-title":"Nat Genet"},{"key":"BFleu2008162_CR58","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","volume":"103","author":"ML Loh","year":"2004","unstructured":"Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, Lieuw KH et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 2004; 103: 2325\u20132331.","journal-title":"Blood"},{"key":"BFleu2008162_CR59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2004-11-4207","volume":"106","author":"S Schubbert","year":"2005","unstructured":"Schubbert S, Lieuw K, Rowe SL, Lee CM, Li X, Loh ML et al. Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood 2005; 106: 311\u2013317.","journal-title":"Blood"},{"key":"BFleu2008162_CR60","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","volume":"106","author":"CP Kratz","year":"2005","unstructured":"Kratz CP, Niemeyer CM, Castleberry RP, Cetin M, Bergstrasser E, Emanuel PD et al. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease. Blood 2005; 106: 2183\u20132185.","journal-title":"Blood"},{"key":"BFleu2008162_CR61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 2006; 78: 279\u2013290.","journal-title":"Am J Hum Genet"},{"key":"BFleu2008162_CR62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng0296-137","volume":"12","author":"DA Largaespada","year":"1996","unstructured":"Largaespada DA, Brannan CI, Jenkins NA, Copeland NG . Nf1 deficiency causes Ras-mediated granulocyte\/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia. Nat Genet 1996; 12: 137\u2013143.","journal-title":"Nat Genet"},{"key":"BFleu2008162_CR63","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","volume":"12","author":"G Bollag","year":"1996","unstructured":"Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 1996; 12: 144\u2013148.","journal-title":"Nat Genet"},{"key":"BFleu2008162_CR64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1097-2765(00)80415-3","volume":"5","author":"RA Birnbaum","year":"2000","unstructured":"Birnbaum RA, O\u2019Marcaigh A, Wardak Z, Zhang Y-Y, Dranoff G, Jacks T et al. Nf1 and Gmcsf interact in myeloid leukemogenesis. Mol Cell 2000; 5: 189\u2013195.","journal-title":"Mol Cell"},{"key":"BFleu2008162_CR65","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1073\/pnas.0307203101","volume":"101","author":"BS Braun","year":"2004","unstructured":"Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, Rozmus SC et al. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci USA 2004; 101: 597\u2013602.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2008162_CR66","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI20476","volume":"113","author":"IT Chan","year":"2004","unstructured":"Chan IT, Kutok JL, Williams IR, Cohen S, Kelly L, Shigematsu H et al. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 2004; 113: 528\u2013538.","journal-title":"J Clin Invest"},{"key":"BFleu2008162_CR67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.01.010","volume":"7","author":"MG Mohi","year":"2005","unstructured":"Mohi MG, Williams IR, Dearolf CR, Chan G, Kutok JL, Cohen S et al. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 2005; 7: 179\u2013191.","journal-title":"Cancer Cell"},{"key":"BFleu2008162_CR68","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4161\/cc.5.15.3128","volume":"5","author":"CP Kratz","year":"2006","unstructured":"Kratz CP, Schubbert S, Bollag G, Niemeyer CM, Shannon KM, Zenker M . Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. Cell Cycle 2006; 5: 1607\u20131611.","journal-title":"Cell Cycle"},{"key":"BFleu2008162_CR69","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/138945007780830773","volume":"8","author":"C Flotho","year":"2007","unstructured":"Flotho C, Kratz C, Niemeyer CM . Targeting RAS signaling pathways in juvenile myelomonocytic leukemia. Curr Drug Targets 2007; 8: 715\u2013725.","journal-title":"Curr Drug Targets"},{"key":"BFleu2008162_CR70","doi-asserted-by":"crossref","unstructured":"Emanuel PD . RAS pathway mutations in juvenile myelomonocytic leukemia. Acta Haematol 2008, (in press).","DOI":"10.1159\/000140632"},{"key":"BFleu2008162_CR71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","volume":"38","author":"S Schubbert","year":"2006","unstructured":"Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet 2006; 38: 331\u2013336.","journal-title":"Nat Genet"},{"key":"BFleu2008162_CR72","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","volume":"39","author":"AE Roberts","year":"2007","unstructured":"Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 2007; 39: 70\u201374.","journal-title":"Nat Genet"},{"key":"BFleu2008162_CR73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","volume":"39","author":"M Tartaglia","year":"2007","unstructured":"Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 2007; 39: 75\u201379.","journal-title":"Nat Genet"},{"key":"BFleu2008162_CR74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng0107-8","volume":"39","author":"K Shannon","year":"2007","unstructured":"Shannon K, Bollag G . Sending out an SOS. Nat Genet 2007; 39: 8\u20139.","journal-title":"Nat Genet"},{"key":"BFleu2008162_CR75","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/sj.leu.2404620","volume":"21","author":"CP Kratz","year":"2007","unstructured":"Kratz CP, Niemeyer CM, Thomas C, Bauhuber S, Matejas V, Bergstrasser E et al. Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia. Leukemia 2007; 21: 1108\u20131109.","journal-title":"Leukemia"},{"key":"BFleu2008162_CR76","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3324\/haematol.11493","volume":"92","author":"ACH de Vries","year":"2007","unstructured":"de Vries ACH, Stam RW, Kratz CP, Zenker M, Niemeyer CM, van den Heuvel-Eibrink MM et al. Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia. Haematologica 2007; 92: 1574\u20131575.","journal-title":"Haematologica"},{"key":"BFleu2008162_CR77","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3324\/haematol.11201","volume":"92","author":"ACH de Vries","year":"2007","unstructured":"de Vries ACH, Stam RW, Schneider P, Niemeyer CM, Van Wering ER, Haas OA et al. Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia. Haematologica 2007; 92: 1557\u20131560.","journal-title":"Haematologica"},{"key":"BFleu2008162_CR78","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.leu.2404484","volume":"21","author":"M Zecca","year":"2007","unstructured":"Zecca M, Bergamaschi G, Kratz C, Bergstrasser E, Danesino C, De Filippi P et al. JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia. Leukemia 2007; 21: 367\u2013369.","journal-title":"Leukemia"},{"key":"BFleu2008162_CR79","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood.V61.6.1098.1098","volume":"61","author":"HG Herrod","year":"1983","unstructured":"Herrod HG, Dow LW, Sullivan JL . Persistent Epstein\u2013Barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studies. Blood 1983; 61: 1098\u20131104.","journal-title":"Blood"},{"key":"BFleu2008162_CR80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00043426-199023000-00007","volume":"12","author":"MA Kirby","year":"1990","unstructured":"Kirby MA, Weitzman S, Freedman MH . Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection. J Pediatr Hematol Oncol 1990; 12: 292\u2013296.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2008162_CR81","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00043426-200202000-00016","volume":"24","author":"A Lorenzana","year":"2002","unstructured":"Lorenzana A, Lyons H, Sawaf H, Higgins M, Carrigan D, Emanuel PD . Human herpes virus 6 infection mimicking juvenile myelomonocytic leukemia in an infant. J Pediatr Hematol Oncol 2002; 24: 136\u2013141.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2008162_CR82","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.mph.0000140653.50344.5c","volume":"26","author":"A Manabe","year":"2004","unstructured":"Manabe A, Yoshimasu T, Ebihara Y, Yagasaki H, Wada M, Ishikawa K et al. Viral infections in juvenile myelomonocytic leucemia: prevalence and clinical implications. J Pediatr Hematol Oncol 2004; 26: 636\u2013641.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2008162_CR83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archpedi.1968.02100020377005","volume":"116","author":"JA Noonan","year":"1968","unstructured":"Noonan JA . Hypertelorism with turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child 1968; 116: 373\u2013380.","journal-title":"Am J Dis Child"},{"key":"BFleu2008162_CR84","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.2003.04361.x","volume":"121","author":"SJ Passmore","year":"2003","unstructured":"Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA . Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol 2003; 121: 758\u2013767.","journal-title":"Br J Haematol"},{"key":"BFleu2008162_CR85","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2006-09-046649","volume":"109","author":"K Matsuda","year":"2007","unstructured":"Matsuda K, Shimada A, Yoshida N, Ogawa A, Watanabe A, Yajima S et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leucemia with specific RAS mutations. Blood 2007; 109: 5477\u20135480.","journal-title":"Blood"},{"key":"BFleu2008162_CR86","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","volume":"105","author":"F Locatelli","year":"2005","unstructured":"Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial. Blood 2005; 105: 410\u2013419.","journal-title":"Blood"},{"key":"BFleu2008162_CR87","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bmt.1704438","volume":"33","author":"U Yusuf","year":"2004","unstructured":"Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transpl 2004; 33: 805\u2013814.","journal-title":"Bone Marrow Transpl"},{"key":"BFleu2008162_CR88","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.0007-1048.2001.03333.x","volume":"116","author":"FO Smith","year":"2002","unstructured":"Smith FO, King R, Nelson G, Wagner JE, Robertson KA, Sanders JE et al. Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. Br J Haematol 2002; 116: 716\u2013724.","journal-title":"Br J Haematol"},{"key":"BFleu2008162_CR89","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.leu.2403721","volume":"19","author":"A Yoshimi","year":"2005","unstructured":"Yoshimi A, Bader P, Matthes-Martin S, Stary J, Sedlacek P, Duffner U et al. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 2005; 19: 971\u2013977.","journal-title":"Leukemia"},{"key":"BFleu2008162_CR90","first-page":"434","volume":"20","author":"WG Woods","year":"2002","unstructured":"Woods WG, Barnard DR, Alonzo TA, Buckley JD, Kobrinsky N, Arthur DC et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. J Clin Oncol 2002; 20: 434\u2013440.","journal-title":"J Clin Oncol"},{"key":"BFleu2008162_CR91","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.21038","volume":"49","author":"E Berstraesser","year":"2007","unstructured":"Berstraesser E, Hasle H, Rogge T, Fischer A, Zimmerman M, Noellke P et al. Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria. Pediatr Blood Cancer 2007; 49: 629\u2013633.","journal-title":"Pediatr Blood Cancer"},{"key":"BFleu2008162_CR92","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJM199412223312503","volume":"331","author":"RP Castleberry","year":"1994","unstructured":"Castleberry RP, Emanuel PD, Zuckerman KS, Cohn S, Strauss L, Byrd RL et al. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N Engl J Med 1994; 331: 1680\u20131684.","journal-title":"N Engl J Med"},{"key":"BFleu2008162_CR93","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.V99.7.2615","volume":"99","author":"F Bernard","year":"2002","unstructured":"Bernard F, Thomas C, Emile JF, Hercus T, Cassinat B, Chomienne C et al. Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia. Blood 2002; 99: 2615\u20132616.","journal-title":"Blood"},{"key":"BFleu2008162_CR94","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1182\/blood.V99.11.4147","volume":"99","author":"PO Iversen","year":"2002","unstructured":"Iversen PO, Emanuel PD, Sioud M . Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leucemia cell growth. Blood 2002; 99: 4147\u20134153.","journal-title":"Blood"},{"key":"BFleu2008162_CR95","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood-2002-07-2250","volume":"101","author":"AL Aiyagari","year":"2003","unstructured":"Aiyagari AL, Taylor BR, Aurora V, Young SG, Shannon KM . Hematologic effects of inactivating the Ras processing enzyme Rce1. Blood 2003; 101: 2250\u20132252.","journal-title":"Blood"},{"key":"BFleu2008162_CR96","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/annonc\/mdi233","volume":"16","author":"H Shimada","year":"2005","unstructured":"Shimada H, Shima H, Shimasaki N, Yoshihara H, Mori T, Takahashi T . Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation. Ann Oncol 2005; 16: 1400.","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"BFleu2008162_CR97","first-page":"727a","volume":"106","author":"R Castleberry","year":"2005","unstructured":"Castleberry R, Loh M, Jayaprakash N, Peterson A, Casey V, Chang M et al. Phase II window study of the farnesyltransferase inhibitor R115777 (Zarnestra) in untreated juvenile myelomonocytic leukemia (JMML): a Children's Oncology Group study. Blood 2005; 106 (Suppl 1): 727a\u2013728a.","journal-title":"Blood"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2008162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008162","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:12:17Z","timestamp":1648725137000},"score":11.74768,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2008162"}},"issued":{"date-parts":[[2008,6,12]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BFleu2008162"],"URL":"https:\/\/doi.org\/10.1038\/leu.2008.162","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2008,6,12]]},"assertion":[{"value":"14 March 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T23:19:36Z","timestamp":1648855176610},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1993,9,1]],"date-time":"1993-09-01T00:00:00Z","timestamp":746841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1993,9]]},"DOI":"10.1016\/0145-2126(93)90118-5","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:53:46Z","timestamp":1082714026000},"page":"821","source":"Crossref","is-referenced-by-count":0,"title":["Leukemia"],"prefix":"10.1016","volume":"17","author":[{"given":"Peter","family":"Reizenstein","sequence":"first","affiliation":[]}],"member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212693901185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212693901185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T09:54:05Z","timestamp":1549792445000},"score":11.739203,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0145212693901185"}},"issued":{"date-parts":[[1993,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1993,9]]}},"alternative-id":["0145212693901185"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(93)90118-5","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[1993,9]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T20:34:33Z","timestamp":1648931673376},"reference-count":0,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1038\/41375.1476-5551","type":"journal","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T10:16:45Z","timestamp":1563445005000},"source":"Crossref","is-referenced-by-count":0,"title":["Leukemia"],"prefix":"10.1038","member":"297","language":"en","deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T10:16:45Z","timestamp":1563445005000},"score":11.705776,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/leu\/"}},"short-title":["Leukemia"],"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1038\/41375.1476-5551","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}]},{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:54:42Z","timestamp":1777035282800,"version":"3.51.4"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.leukres.2008.09.022","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T08:36:48Z","timestamp":1225528608000},"page":"749","source":"Crossref","is-referenced-by-count":1,"title":["Reversing the multidrug resistance in acute leukemia: Until the leukemia initiating cell?"],"prefix":"10.1016","volume":"33","author":[{"given":"R\u00e9gis T.","family":"Costello","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.09.022_bib1","unstructured":"Marcelletti JF, Multani PS, Lancet JE, Baer MR, Sikic BI. Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukaemia. Leuk Res, in press."},{"key":"10.1016\/j.leukres.2008.09.022_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"Cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2008.09.022_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2008.09.022_bib4","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood.V92.11.4325","article-title":"Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD341\/CD712\/HLA-DR2","volume":"92","author":"Blair","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.022_bib5","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood.V86.8.2906.2906","article-title":"Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD341 subpopulations","volume":"86","author":"Haase","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.022_bib6","first-page":"4403","article-title":"Human acute myeloid leukemia CD34+\/CD38\u2212 progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities","volume":"60","author":"Costello","year":"2000","journal-title":"Cancer Res"}],"container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T20:43:20Z","timestamp":1589057000000},"score":11.584331,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608004347"}},"issued":{"date-parts":[[2009,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0145212608004347"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.09.022","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[2009,6]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T20:04:43Z","timestamp":1720382683862},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/s0145-2126(09)70018-9","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T04:39:08Z","timestamp":1241411948000},"page":"S15","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["19 Chronic myelomonocytic leukemia"],"prefix":"10.1016","volume":"33","author":[{"given":"D.","family":"Bowen","sequence":"first","affiliation":[]}],"member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609700189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609700189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:58:50Z","timestamp":1545267530000},"score":11.5678425,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609700189"}},"issued":{"date-parts":[[2009,5]]},"references-count":0,"alternative-id":["S0145212609700189"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(09)70018-9","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[2009,5]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T20:04:44Z","timestamp":1720382684341},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/s0145-2126(09)70020-7","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T04:39:08Z","timestamp":1241411948000},"page":"S17","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["21 Juvenile myelomonocytic leukemia"],"prefix":"10.1016","volume":"33","author":[{"given":"C.","family":"Flotho","sequence":"first","affiliation":[]}],"member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609700207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609700207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:58:49Z","timestamp":1545267529000},"score":11.545142,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609700207"}},"issued":{"date-parts":[[2009,5]]},"references-count":0,"alternative-id":["S0145212609700207"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(09)70020-7","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[2009,5]]}},{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T01:22:59Z","timestamp":1726104179074},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[1997,6,1]]},"DOI":"10.1038\/sj.leu.2400730","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:23:00Z","timestamp":1031163780000},"page":"897-919","source":"Crossref","is-referenced-by-count":0,"title":["Leukemia Research Fund Abstracts"],"prefix":"10.1038","volume":"11","member":"297","container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2400730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2400730","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2400730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:07:34Z","timestamp":1648753654000},"score":11.54224,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2400730"}},"issued":{"date-parts":[[1997,6,1]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6,1]]}},"alternative-id":["BF2400730"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2400730","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[1997,6,1]]}},{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:14:28Z","timestamp":1697393668211},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2002,4,1]]},"DOI":"10.1038\/sj.leu.2402521","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:42:14Z","timestamp":1031251334000},"page":"753-754","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mixed allogeneic chimerism and graft-versus-leukemia effects in acute myeloid leukemia"],"prefix":"10.1038","volume":"16","author":[{"given":"R","family":"Storb","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2002,4,16]]},"reference":[{"key":"BF2402521_CR1","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","volume":"89","author":"R Storb","year":"1997","unstructured":"Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, Leisenring W, Schulman H . Stable mixed hematopietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression afater marrow transplantation Blood 1997 89: 3048\u20133054","journal-title":"Blood"},{"key":"BF2402521_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0360-3016(93)90207-C","volume":"26","author":"R Storb","year":"1993","unstructured":"Storb R, Raff RF, Graham T, Appelbaum FR, Deeg HJ, Schuening FG, Schulman H, Pepe M . Marrow toxicity of fractionated versus single dose total body irradiation is identical in a canine model Int J Radiat Oncol Biol Phys 1993 26: 275\u2013283","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF2402521_CR3","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1182\/blood.V95.10.3262","volume":"95","author":"GE Georges","year":"2000","unstructured":"Georges GE, Storb R, Thompson JD, Yu C, Gooley T, Bruno B, Nash RA . Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation Blood 2000 95: 3262\u20133269","journal-title":"Blood"},{"key":"BF2402521_CR4","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers MED, Georges GE, Grumet FC, Kiern H-P, Torok-Storb B, Yu C, Blume KG, Storb RF . Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Blood 2001 97: 3390\u20133400","journal-title":"Blood"},{"key":"BF2402521_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/sj.leu.2402034","volume":"15","author":"R Storb","year":"2001","unstructured":"Storb R . Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia? Leukemia 2001 15: 662\u2013663","journal-title":"Leukemia"},{"key":"BF2402521_CR6","first-page":"517a","volume":"96","author":"BM Sandmaier","year":"2000","unstructured":"Sandmaier BM, Wilbur DS, Hamlin D, Santos EB, Storb R . Nonmyeloablative marrow transplant conditioning: use of antibody-targeted Bi-213 Blood 2000 96: 517a (Abstr. 2226)","journal-title":"Blood"}],"container-title":["Leukemia"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402521","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:14:56Z","timestamp":1648761296000},"score":11.521005,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402521"}},"issued":{"date-parts":[[2002,4,1]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4,1]]}},"alternative-id":["BF2402521"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402521","ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"published":{"date-parts":[[2002,4,1]]},"assertion":[{"value":"11 September 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T08:47:11Z","timestamp":1709282831706},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/s0145-2126(03)00400-4","type":"journal-article","created":{"date-parts":[[2004,5,25]],"date-time":"2004-05-25T20:28:55Z","timestamp":1085516935000},"page":"661-666","source":"Crossref","is-referenced-by-count":0,"title":["Apoptosis in acute leukemia"],"prefix":"10.1016","volume":"28","author":[{"given":"D","family":"SCHULER","sequence":"first","affiliation":[]}],"member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0145-2126(03)00400-4?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0145-2126(03)00400-4?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2015,10,11]],"date-time":"2015-10-11T05:58:06Z","timestamp":1444543086000},"score":11.497322,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603004004"}},"issued":{"date-parts":[[2004,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0145-2126(03)00400-4"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(03)00400-4","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[2004,7]]}},{"indexed":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:46:51Z","timestamp":1713260811678},"reference-count":2,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1016\/s0145-2126(00)00023-0","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T02:52:42Z","timestamp":1027651962000},"page":"637","source":"Crossref","is-referenced-by-count":6,"title":["Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine"],"prefix":"10.1016","volume":"24","author":[{"given":"Prabha","family":"Seshadri","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(00)00023-0_BIB1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0145-2126(99)00090-9","article-title":"Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature","volume":"23","author":"Al-Fiar","year":"1999","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/S0145-2126(00)00023-0_BIB2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<957::AID-CNCR22>3.0.CO;2-Z","article-title":"Long term follow up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced indolent non-Hodgkin\u2019s lymphoma","volume":"82","author":"Kong","year":"1998","journal-title":"Cancer"}],"container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212600000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212600000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T04:54:04Z","timestamp":1555217644000},"score":11.497317,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212600000230"}},"issued":{"date-parts":[[2000,7]]},"references-count":2,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0145212600000230"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(00)00023-0","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[2000,7]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:18:19Z","timestamp":1648513099355},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Leukemia"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/s1931-6925(12)60025-4","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T22:17:08Z","timestamp":1361485028000},"page":"133","source":"Crossref","is-referenced-by-count":0,"title":["Selected Clinical Trials in Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"1","member":"78","container-title":["Clinical Leukemia"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931692512600254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931692512600254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T13:59:06Z","timestamp":1539871146000},"score":11.476435,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931692512600254"}},"issued":{"date-parts":[[2006,12]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1931692512600254"],"URL":"https:\/\/doi.org\/10.1016\/s1931-6925(12)60025-4","ISSN":["1931-6925"],"issn-type":[{"value":"1931-6925","type":"print"}],"published":{"date-parts":[[2006,12]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T19:58:11Z","timestamp":1720382291221},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s0145-2126(14)70045-1","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T03:51:46Z","timestamp":1413949906000},"page":"S22","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["SP-054 ACUTE MYELOGENOUS LEUKEMIA"],"prefix":"10.1016","volume":"38","author":[{"given":"Burak","family":"Gumuscu","sequence":"first","affiliation":[]}],"member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614700451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614700451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T06:25:05Z","timestamp":1538115905000},"score":11.459585,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212614700451"}},"issued":{"date-parts":[[2014,10]]},"references-count":0,"alternative-id":["S0145212614700451"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(14)70045-1","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T10:30:40Z","timestamp":1649845840159},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1997,4,1]],"date-time":"1997-04-01T00:00:00Z","timestamp":859852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1997,4]]},"DOI":"10.1016\/s0145-2126(96)00101-4","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T16:14:01Z","timestamp":1027613641000},"page":"351-352","source":"Crossref","is-referenced-by-count":3,"title":["Acute myeloid leukemia M2B (subacute myeloid leukemia) in China"],"prefix":"10.1016","volume":"21","author":[{"given":"Zhijian","family":"Xiao","sequence":"first","affiliation":[]},{"given":"Yushu","family":"Hao","sequence":"additional","affiliation":[]},{"given":"Shougeng","family":"Bian","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(96)00101-4_BIB1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0145-2126(95)00020-O","article-title":"Translocation (8;21) in acute myeloid leukemia: When to treat? That is the question","volume":"19","author":"Bennett","year":"1995","journal-title":"Leukemia Research"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB2","first-page":"714","article-title":"Clinical manifestation and diagnosis of subacute myelogenous leukemia","volume":"12","author":"Yan","year":"1964","journal-title":"Chinese Journal of Internal Medicine"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB3","first-page":"138","article-title":"Characteristics of cytochemistry in M2b leukemic cells","volume":"13","author":"Lin","year":"1992","journal-title":"Chinese Journal of Hematology"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB4","first-page":"39","article-title":"An electron microscopic study of subacute myelogenous leukemic cells","volume":"19","author":"Qi","year":"1980","journal-title":"Chinese Journal of Internal Medicine"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0165-4608(87)90075-6","article-title":"Consistent chromosomal changes in Chinese patients with acute nonlymphocytic leukemia","volume":"26","author":"Li","year":"1987","journal-title":"Cancer Genetic & Cytogenetic"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB6","first-page":"10","article-title":"Subacute myelogenous leukemia is a special subtype among M2","volume":"9","author":"Bian","year":"1988","journal-title":"Chinese Journal of Hematology"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB7","first-page":"190","article-title":"t(8;21) acute myelogenous leukemia: an analysis of 30 cases","volume":"16","author":"Xiao","year":"1995","journal-title":"Chinese Journal of Hematology"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB8","article-title":"Comparing study of biologic features of acute myeloid leukemia M2b and M2a","author":"Xiao","year":"1996","journal-title":"Chinese Journal of Internal Medicine"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB9","first-page":"563","article-title":"Detection of ETO gene rearrangement in patients with AML-M2b","volume":"15","author":"Xiao","year":"1994","journal-title":"Chinese Journal of Hematology"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB10","first-page":"11","article-title":"Detection of AML1 gene rearrangement in patients with acute myeloid leukemia-M2b (AML-M2b)","volume":"16","author":"Xiao","year":"1995","journal-title":"Chinese Journal of Hematology"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB11","first-page":"9","article-title":"Detection of AML1\/ETO fusion mRNA in acute myelogenous leukemia-M2b","volume":"15","author":"Wang","year":"1994","journal-title":"Chinese Journal of Hematology"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB12","first-page":"303","article-title":"Verification of AML1 gene rearrangement and\/or AML1-ETO fusion transcript in two AML-M2b patients without (8;21) translocation","volume":"11","author":"Xiao","year":"1994","journal-title":"Chinese Journal of Medicine & Genetics"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB13","first-page":"399","article-title":"Studies on rearrangement and fusion gene of AML1 and MTG8 in acute myeloid leukemia M2b","volume":"75","author":"Wang","year":"1995","journal-title":"Chinese Journal of Medicine"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB14","first-page":"1533","article-title":"Correlation between cell morphology and expression of the AML1\/ETO chimeric transcript in patients with myeloid leukemia without the t(8;21)","volume":"8","author":"Nucifora","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1996.415954.x","article-title":"Molecular detection of t(8;21)\/AML1-ETO in AML M1\/M2: Correlation with cytogenetics, morphology and immunophenotype","volume":"92","author":"Andrien","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB16","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0145-2126(91)90185-V","article-title":"Prognostic implications and characterization of the blast cell population in the myelodysplastic syndrome","volume":"15","author":"Goasguen","year":"1991","journal-title":"Leukemia Research"},{"key":"10.1016\/S0145-2126(96)00101-4_BIB17","series-title":"Report of the National Cancer Institute sponsored workshop on definitions of diagnosis and response in acute myleloid leukemia","first-page":"813","volume":"8","author":"Cheson","year":"1990"}],"container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212696001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212696001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T08:23:16Z","timestamp":1556266996000},"score":11.441836,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212696001014"}},"issued":{"date-parts":[[1997,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["S0145212696001014"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(96)00101-4","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[1997,4]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:30:25Z","timestamp":1648819825897},"reference-count":0,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1038\/41376.2044-5229","type":"journal","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T10:16:46Z","timestamp":1563445006000},"source":"Crossref","is-referenced-by-count":0,"title":["Leukemia Supplements"],"prefix":"10.1038","member":"297","language":"en","deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T10:16:46Z","timestamp":1563445006000},"score":11.42688,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/leusup\/"}},"short-title":["Leukemia Suppl"],"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1038\/41376.2044-5229","ISSN":["2044-5210","2044-5229"],"issn-type":[{"value":"2044-5210","type":"print"},{"value":"2044-5229","type":"electronic"}]},{"indexed":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T20:23:41Z","timestamp":1698265421190},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1993,3,1]],"date-time":"1993-03-01T00:00:00Z","timestamp":730944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1993,3]]},"DOI":"10.1016\/0145-2126(93)90001-2","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T09:46:32Z","timestamp":1082367992000},"page":"197-198","source":"Crossref","is-referenced-by-count":2,"title":["Leukemia and electromagnetic fields"],"prefix":"10.1016","volume":"17","author":[{"given":"Peter","family":"Reizenstein","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/0145-2126(93)90001-2_BIB1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/oxfordjournals.aje.a112681","article-title":"Electrical wiring configurations and childhood cancer","volume":"109","author":"Wertheimer","year":"1979","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/0145-2126(93)90001-2_BIB2","series-title":"Technical Report, Proceedings of the International Conference on Electrical and Magnetic fields in Medicine and Biology","article-title":"Overhead power lines and childhood cancer","author":"Myers","year":"1985"},{"issue":"1","key":"10.1016\/0145-2126(93)90001-2_BIB3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/oxfordjournals.aje.a114943","article-title":"Case-control study of childhood cancer and exposure to 60-Hertz magnetic fields","volume":"128","author":"Savitz","year":"1988","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/0145-2126(93)90001-2_BIB4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/oxfordjournals.aje.a112899","article-title":"Electrical wiring configurations and childhood leukemia in Rhode Island","volume":"111","author":"Fulton","year":"1980","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/0145-2126(93)90001-2_BIB5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/bem.2250070209","article-title":"50-Hz electromagnetic environments and the incidence of childhood tumours in Stockholm county","volume":"7","author":"Tomenius","year":"1986","journal-title":"Bioelectromagnetics"},{"key":"10.1016\/0145-2126(93)90001-2_BIB6","unstructured":"Feychlig M. & Ahlbom A. Magnetic fields and cancer in people residing near Swedish high voltage power lines. Report published by the Institute for Environmental Medicine, Karolinska Institute, 104 01 Stockholm, Sweden."},{"key":"10.1016\/0145-2126(93)90001-2_BIB7","series-title":"Risk for cancer in children living near power lines (in Danish)","author":"Olsen","year":"1992"},{"key":"10.1016\/0145-2126(93)90001-2_BIB8","first-page":"47","article-title":"Leukemia and occupational exposure to electromagnetic fields: review of epidemiological surveys","volume":"29","author":"Savitz","year":"1978","journal-title":"J. occup. Med."},{"key":"10.1016\/0145-2126(93)90001-2_BIB9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/jnci\/61.5.1195","article-title":"Secondary primary neoplasms following ovarian cancer","volume":"61","author":"Reimer","year":"1978","journal-title":"J. natn. Cancer Inst."},{"key":"10.1016\/0145-2126(93)90001-2_BIB10","first-page":"99","article-title":"Second cancer following cancer of the breast in Connecticut 1935\u20131982","volume":"68","author":"Harvey","year":"1985","journal-title":"Natl Cancer Inst. Monogr."}],"container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212693900012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212693900012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T13:51:17Z","timestamp":1549893077000},"score":11.418126,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0145212693900012"}},"issued":{"date-parts":[[1993,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,3]]}},"alternative-id":["0145212693900012"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(93)90001-2","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[1993,3]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T07:09:57Z","timestamp":1648883397637},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.leukres.2003.10.030","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T11:49:26Z","timestamp":1084276166000},"page":"771","source":"Crossref","is-referenced-by-count":0,"title":["Biologic Therapy of Leukemia"],"prefix":"10.1016","volume":"28","author":[{"given":"Jane L","family":"Liesveld","sequence":"first","affiliation":[]}],"member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603003989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603003989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T14:25:30Z","timestamp":1549722330000},"score":11.412757,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603003989"}},"issued":{"date-parts":[[2004,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0145212603003989"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2003.10.030","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[2004,7]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:28:13Z","timestamp":1648992493361},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1989]]},"DOI":"10.1016\/0145-2126(89)90024-6","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T13:46:32Z","timestamp":1082382392000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Leukemia research thirteen years on"],"prefix":"10.1016","volume":"13","author":[{"given":"Terry","family":"Hamblin","sequence":"first","affiliation":[]}],"member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212689900246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212689900246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T18:24:23Z","timestamp":1549909463000},"score":11.406656,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0145212689900246"}},"issued":{"date-parts":[[1989]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989]]}},"alternative-id":["0145212689900246"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(89)90024-6","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[1989]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:37:21Z","timestamp":1648827441214},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Leukemia"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/s1931-6925(13)60069-8","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T22:08:13Z","timestamp":1361484493000},"page":"251","source":"Crossref","is-referenced-by-count":1,"title":["Selected Clinical Trials in Leukemia and MDS"],"prefix":"10.1016","volume":"1","member":"78","container-title":["Clinical Leukemia"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931692513600698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931692513600698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T13:59:44Z","timestamp":1539871184000},"score":11.402686,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931692513600698"}},"issued":{"date-parts":[[2007,6]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1931692513600698"],"URL":"https:\/\/doi.org\/10.1016\/s1931-6925(13)60069-8","ISSN":["1931-6925"],"issn-type":[{"value":"1931-6925","type":"print"}],"published":{"date-parts":[[2007,6]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T19:57:30Z","timestamp":1720382250996},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1991,1]]},"DOI":"10.1016\/0145-2126(91)90327-p","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T09:46:32Z","timestamp":1082367992000},"page":"1","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["(A4) Chronic myelomonocytic leukemia (CMML)"],"prefix":"10.1016","volume":"15","author":[{"given":"Robert V.","family":"Pierre","sequence":"first","affiliation":[]}],"member":"78","container-title":["Leukemia Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:014521269190327P?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:014521269190327P?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T13:28:42Z","timestamp":1549891722000},"score":11.399034,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/014521269190327P"}},"issued":{"date-parts":[[1991,1]]},"references-count":0,"alternative-id":["014521269190327P"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(91)90327-p","ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"published":{"date-parts":[[1991,1]]}}],"items-per-page":20,"query":{"start-index":0,"search-terms":null}}}